You're reading the free version. Trader adds the live tape and alerts.
Start tracking
HALO Sale Disclosure
Posard Matthew L. · SEC Form 4 · Filed Sep 17, 2026
Sale
Calculated transaction value
$961.12K
Posard Matthew L. Director
HALO
Transaction date
Sep 16, 2026
Public filing date
Sep 17, 2026
Filing lag
Filed 1 day later
HALO daily price context
Close on/before transaction
$108.44
Sep 16, 2026
First close after public filing
$112.45
Sep 18, 2026
30-day return after filing
+8.94%
Through Oct 19, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 8,896 shares @ $108.04
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001159036-26-000123
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$2.05M
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Halozyme Therapeutics, Inc. HALO | Sale | Sep 16, 2026 | $329.01K |
| Halozyme Therapeutics, Inc. HALO | Sale | Sep 16, 2026 | $320.48K |
| Halozyme Therapeutics, Inc. HALO Current | Sale | Sep 16, 2026 | $961.12K |
| Halozyme Therapeutics, Inc. HALO | Sale | Sep 16, 2026 | $435.96K |